Angellotti Domenico, Pfluger Marc, Maznyczka Annette, Tomii Daijiro, Nakase Masaaki, Stortecky Stefan, Lanz Jonas, Samim Daryoush, Reineke David, Praz Fabien, Windecker Stephan, Pilgrim Thomas
Department of Cardiology, Bern University Hospital, Bern, Switzerland; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Department of Cardiology, Bern University Hospital, Bern, Switzerland.
JACC Adv. 2025 May 22;4(6 Pt 1):101834. doi: 10.1016/j.jacadv.2025.101834.
Noncoaxial placement of transcatheter heart valves (THVs) relative to the native aortic annulus is occasionally detected on fluoroscopy after transcatheter aortic valve replacement (TAVR).
This study aimed to evaluate the impact of noncoaxial TAVR deployment on clinical outcomes.
We retrospectively evaluated consecutive patients undergoing transfemoral TAVR in the Bern transcatheter aortic valve implantation registry. Coaxiality between the native annulus and the THV was measured using the 3-cusp view on fluoroscopic images and was defined as the angle between a line intersecting the lower points of native cusps and a line intersecting the lower hinge points of the prosthesis frame. Patients were categorized according to tertiles of coaxiality.
Among 2,025 patients (mean age 81.6 ± 6.5 years, mean Society of Thoracic Surgeons Predicted Risk of Mortality 4.2% ± 3.3%) undergoing TAVR with contemporary devices between February 2014 and June 2023, the mean axial angulation of the device relative to the native annulus was 4.1°. According to Valve Academic Research Consortium-3 criteria, patients in the highest tertile of THV axial angle (range, 4.8-21.7°) had reduced device early safety (56.2% vs 82.7%; aHR: 0.67; 95% CI: 0.59-0.76; P < 0.001) and higher rates of stage-2 bioprosthetic valve failure at 1-year follow-up (1.5% vs 0.7%; HR: 3.47; 95% CI: 1.26-9.54; P = 0.016), compared to those with coaxial valve positioning (range, 0.1-3.0). Left ventricle outflow tract calcium volume, predilatation, and valve type were independent predictors of noncoaxial valve implantation.
Noncoaxial THV deployment is associated with impaired valve early safety and increased risk of bioprosthetic valve failure 1 year after TAVR.
经导管主动脉瓣置换术(TAVR)后,在透视检查中偶尔会发现经导管心脏瓣膜(THV)相对于天然主动脉瓣环的非同轴放置情况。
本研究旨在评估非同轴TAVR植入对临床结局的影响。
我们回顾性评估了伯尔尼经导管主动脉瓣植入登记处连续接受经股动脉TAVR的患者。使用透视图像上的三叶瓣视图测量天然瓣环与THV之间的同轴度,其定义为与天然瓣叶下点相交的线和与假体框架下铰链点相交的线之间的夹角。根据同轴度三分位数对患者进行分类。
在2014年2月至2023年6月期间使用当代器械进行TAVR的2025例患者(平均年龄81.6±6.5岁,胸外科医师协会预测死亡率平均为4.2%±3.3%)中,器械相对于天然瓣环的平均轴向角度为4.1°。根据瓣膜学术研究联盟-3标准,THV轴向角度最高三分位数(范围为4.8-21.7°)的患者器械早期安全性降低(56.2%对82.7%;校正后风险比:0.67;95%置信区间:0.59-0.76;P<0.001),与同轴瓣膜定位(范围为0.1-3.0)的患者相比,1年随访时2期生物瓣膜失败率更高(1.5%对0.7%;风险比:3.47;95%置信区间:1.26-9.54;P=0.016)。左心室流出道钙体积、预扩张和瓣膜类型是非同轴瓣膜植入的独立预测因素。
非同轴THV植入与瓣膜早期安全性受损以及TAVR术后1年生物瓣膜失败风险增加相关。